稳健医疗跌6.68% 某券商在去年最高位上调评级至买入

Core Viewpoint - The report highlights that Steady Medical (300888.SZ) is experiencing a recovery in its stock performance, with a recent peak price of 44.45 yuan, and emphasizes the company's sustainable growth in its core business areas [1] Group 1: Stock Performance - Steady Medical's stock closed at 40.10 yuan, with a decline of 6.68%, and a total market capitalization of 23.351 billion yuan [1] - The stock saw a consecutive increase over four trading days from December 10 to December 13, with respective gains of 0.40%, 8.55%, 2.77%, and 2.07% [1] - On December 16, 2024, the stock reached its highest price of the previous year at 44.45 yuan, closing at 43.26 yuan with a gain of 2.12% [1] Group 2: Research Insights - Tianfeng Securities published a report titled "Steady Medical (300888): All-Cotton Era Sustainable Development, Medical Export Provides New Opportunities," authored by analyst Sun Haiyang [1] - The report states that the public health events' impact on the medical business has passed, and the All-Cotton Era has returned to a healthy and sustainable growth trajectory without sacrificing profit and gross margin [1] - The report identifies that the medical production capacity and brand expansion overseas will provide new development opportunities for the company [1] - The earnings forecast has been adjusted, and Steady Medical has been upgraded to a "Buy" rating [1]